Epcoritamab,rituximab,cyclophosphamide,doxorubicin,vincristine,prednisone,lenalidomide,bendamustine,cytarabine,dexamethasone,oxaliplatin,carboplatin,gemcitabine,ifosfamide
Genmab,Abbvie
['lenalidomide', 'ritux', 'lymsm', 'nhl', 'epcore,nhl,3', 'epcoritamab', 'epcore,nhl,2', 'rituximab', 'epcore,nhl,i,(-ii)']
congress|#asco23 reid merryman discusses the epcore nhl-2 trial evaluating epcoritamab with rituximab+lenalidomide in patients with r/r fl. this combination therapy showed potent antitumor activity and manageable safety profile #lymsm 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm